![Foto de Antonio](/img/nophoto.png)
Antonio
Pineda Lucena
Investigador Senior
Publications (141) Publications de Antonio Pineda Lucena
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
GeNNius: an ultrafast drug-target interaction inference method based on graph neural networks
Bioinformatics (Oxford, England), Vol. 40, Núm. 1
-
HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice
Bone and Joint Research, Vol. 12, Núm. 4, pp. 169-183
-
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer
Cell Death Discovery, Vol. 10, Núm. 1
-
Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model
British Journal of Pharmacology, Vol. 181, Núm. 3, pp. 495-508
2023
-
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity
Biomedicine and Pharmacotherapy, Vol. 169
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
-
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders
Medical Microbiology and Immunology, Vol. 212, Núm. 1, pp. 93-102
-
NMR-Based Mitochondria Metabolomic Profiling: A New Approach To Reveal Cancer-Associated Alterations
Analytical Chemistry, Vol. 95, Núm. 45, pp. 16539-16548
-
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Biology, Vol. 12, Núm. 9
-
Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2022
-
CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage
Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325
-
Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort
Biomedical Journal, Vol. 45, Núm. 4, pp. 654-664
-
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models
Biomedicine and Pharmacotherapy, Vol. 150
-
Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
International Journal of Molecular Medicine, Vol. 49, Núm. 5
-
Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae
Nature Communications, Vol. 13, Núm. 1
-
Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency
Cells, Vol. 11, Núm. 3
-
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches
Cancers, Vol. 14, Núm. 3
-
Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus
Nature Communications, Vol. 13, Núm. 1